Flow Cytometry Market

Recent trends in the flow cytometry market include the incorporation of nanoparticles, the introduction of Anti-TRBC2 conjugated antibodies, the integration of artificial intelligence, multicolor flow cytometry, and advances in fluorescent dyes.

Flow Cytometry Market Scenario

The flow cytometry market was estimated at USD 4.7 billion in 2023 and is projected to reach USD 7.0 billion by 2028 at a CAGR of 8.3% during the forecast period, mainly due to the launch of technologically advanced instruments and software. Key players are investing in innovation to gain a competitive edge, contributing to robust growth and promising prospects in the market.

To know about the assumptions considered for the study download the pdf brochure

Top Trends In The Flow Cytometry Market

Recent trends in the flow cytometry market include the incorporation of nanoparticles, the introduction of Anti-TRBC2 conjugated antibodies, the integration of artificial intelligence, multicolor flow cytometry, and advances in fluorescent dyes. The recent launch of Anti-TRBC2 conjugated antibodies for flow cytometry marks a significant advancement in the field. Anti-TRBC2 T-cell clonality testing involves the use of antibodies targeting the T-cell receptor constant beta chain 2 (TRBC2). This, in combination with TRBC1 antibodies, offers a low-cost, rapid, and specific T-cell clonality test using flow cytometry. The testing is especially useful in cancer research, providing valuable tools to understand and study T-cell populations in diverse biological contexts. The integration of nanotechnology, especially the use of nanoparticles, with flow cytometry is poised to revolutionize cellular analysis. Nanotechnology improves the sensitivity of flow cytometry, impacting diverse fields such as precision medicine and pharmaceuticals. Furthermore, the incorporation of magnetic nanoparticles has expanded the possibilities for magnetic-activated cell sorting (MACS) in flow cytometry systems. This groundbreaking method facilitates the magnetic tagging and sorting of cells, improving the precision of enriching cell populations.

Flow Cytometry Analysis

What is flow cytometry analysis expression?

Flow cytometry analysis of expression, also known as FACS analysis, measures the presence and relative abundance of specific molecules like proteins or DNA within individual cells. Cells are stained with fluorescent probes, then passed one at a time through a laser beam. Detectors capture light signals, and software analyzes them to reveal different cell subpopulations based on their fluorescence intensity, allowing researchers to quantify expression levels, compare across groups, and gain insights into various fields like immunology, cancer biology, and drug discovery.

Flow Cytometry Uses

What is flow cytometry used for?

Flow cytometry, a powerful laser-based technique, delves deep into the world of individual cells. It measures their physical and chemical characteristics, acting like a microscopic detective. From counting and identifying different immune cell types in blood to analyzing protein expression in cancer cells, its applications span diverse fields. It can even help sort specific cell populations for further study. Its versatility makes it a valuable tool for research in immunology, cancer biology, microbiology, and drug discovery, aiding in everything from understanding diseases to developing new treatments.

Flow Cytometry Applications

What is the application of flow cytometry?

Flow cytometry dons many hats in the world of research! It shines a laser on individual cells, analyzing their size, complexity, and specific molecules they express. This unique ability makes it a versatile tool across diverse fields:

1. Immunology: It identifies and counts different immune cell types, crucial for understanding immune response and diseases.
2. Cancer biology: It pinpoints and characterizes cancer cells, analyzes tumor heterogeneity, and even assesses treatment effectiveness.
3. Microbiology: It differentiates various microbial species, aiding in disease diagnosis and environmental monitoring.
4. Stem cell biology: It tracks stem cell differentiation and lineage commitment, unlocking insights into regenerative medicine.
5. Drug discovery: It screens for drugs that alter specific molecule expression, accelerating the development of new therapies.

Flow cytometry offers a microscopic window into the cellular world, providing invaluable information for research and development in numerous fields.

Recent Developments In The Flow Cytometry Market

Prominent players in the flow cytometry market include BD (US), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Luminex Corporation (US), Agilent Technologies, Inc. (US), Sony Group Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMérieux S.A. (France), Cytonome/ST, LLC (US), Sartorius AG (Germany), and Cytek Biosciences, Inc. (US) among others.

These companies are actively involved in the research and development of flow cytometry products as well as the introduction of novel and technologically advanced instruments and consumables. Some of their strategic initiatives include:

1. In January 2024, Beckman Coulter, Inc., a Danaher Corporation company, launched an Anti-TRBC2 conjugated antibody for flow cytometry. The antibody offers enhanced clarity to clinical researchers, aiding in the identification of T-cell neoplasms in various domains, including cancer research. Anti-TRBC2, in combination with Anti-TRBC1 conjugates, can be used for low-cost, rapid, and specific T-cell clonality tests using flow cytometry.
2. In December 2023, Biotium launched Biotium Choice primary antibody conjugates, designed to provide optimal performance in flow cytometry and other applications. Biotium Choice antibody conjugates are available in CF dyes, Astral Leap tandem dyes, and RPE-Astral 616 and APC-Astral 813 dyes. These antibodies are also available in various clones, targeting common markers such as CD3e and CD4 and ensuring reliability and performance. This launch adds significantly to Biotium's portfolio, reinforcing its commitment to providing high-quality tools for life science research.
3. In October 2023, Sony Corporation launched the FP7000 spectral cell sorter with high-speed, high-parameter sorting. The newly launched spectral cell sorter is configurable with up to 6 lasers and 182 detectors, enabling the detection and sorting of cell populations of interest using complex panels comprised of more than 44 colors.
4. In August 2023, Bio-Rad Laboratories, Inc. launched 3 new StarBright dyes (StarBright Red 670, StarBright Blue 700, and StarBright Violet 610) for flow cytometry. These dyes are designed to be compatible with various flow cytometers, including the Bio-Rad ZE5 Cell Analyzer and the S3e Cell Sorter, among others.
5. In May 2023, Sysmex Corporation launched a Clinical Flow Cytometry System in Japan. The system integrates antibody reagents, the Flow Cytometer XF-1600, the Sample Preparation System PS-10, and other related products.
6. In May 2023, BD introduced the BD FACSDiscover S8 Cell Sorter, which integrates advanced spectral flow cytometry with BD’s CellView Image Technology. This technology allows real-time spatial and morphological analysis of cells during sorting. It is recognized as the world's first spectral cell sorter with high-speed cell imaging, offering a unique capability to sort cells based on visual characteristics.

Growth Areas And Opportunities In The Flow Cytometry Market

The rise in the number of collaborations and partnerships for the development of novel technologies is one of the foremost trends in the flow cytometry market. Numerous partnerships and collaborations have been spotted between key market players and SMEs, research institutes, and pharmaceutical companies. These partnerships and collaborations are aimed at expanding product offerings across the globe while helping players improve and strengthen their technical efficiencies and financial base to penetrate emerging markets.

Some of the strategic partnerships/collaborations include:

1. In January 2024, Cytek Biosciences, Inc. entered into an agreement with the Centre for Genomic Regulation (CRG) and Pompeu Fabra University (UPF) to expedite scientific discoveries. As part of the collaboration, Cytek will supply cutting-edge spectral cytometry platforms and trained support personnel to CRG-UPF Flow Cytometry Unit’s headquarters. The partnership aims to leverage Cytek's advanced cell analysis solutions to enhance research capabilities and accelerate scientific breakthroughs.
2. In September 2023, Novartis AG subsidiary Navigate Biopharma entered into a strategic collaboration with BD to develop Flow Cytometry Companion Diagnostics (CDx) solutions. This collaboration aims to enhance clinical drug development by leveraging Navigate BioPharma's expertise in designing and validating biomarker assays for clinical trials. This partnership strives to investigate and create companion diagnostics and tools based on flow cytometry, enhancing solutions for improved clinical decision-making.
3. In May 2023, FlowMetric (a KCAS Company) entered into a collaboration with Cytek Biosciences to implement next-generation flow cytometry technology.
4. In May 2023, BD India partnered with Sehgal Path Lab to establish their third Clinical Center of Excellence (CoE) in Flow Cytometry for Clinical Research. The CoE aims to serve as the National Reference Center for clinical diagnostics applications, reinforcing BD's commitment to advancing research and diagnostics in India. The collaboration is a significant step toward advancing the field of Flow Cytometry in India, fostering innovation and research in clinical settings.
5. In March 2023, BD and the Agency for Science, Technology, and Research (A*STAR) entered into a research collaboration to advance ultra-high dimensional analysis in flow cytometry for immunology research. This partnership aims to enhance the quality of single-cell biological data acquisition, utilizing state-of-the-art technologies and expertise in the field.
6. In April 2023, NanoCellect entered into a partnership with 5 players in different countries --- Shanghai BioHandler Life Technology Co., Ltd. (North China), T&T Wisdom Bio-tech. Co., Ltd. (South China), Medikonia Ltd. (Hong Kong & Macau), Paralab Bio (Spain & Portugal), and Swift Analytical Ltd. (United Kingdom) --- to distribute NanoCellect’s products. This expansion aims to strengthen the company's presence in Asia and Europe.
7. In February 2023, Cytek Biosciences, Inc. partnered with Bio-Rad Laboratories, Inc. to expand its reagent portfolios, enhancing high-parameter panels on Cytek’s Aurora and Northern Lights flow cytometry systems. The collaboration leverages Bio-Rad's expertise in life science research and clinical diagnostics, further strengthening Cytek's capabilities in serving researchers and clinicians worldwide.

AI Is Revolutionizing Flow Cytometry, Providing A Paradigm Shift In Data Analysis And Interpretation

Artificial intelligence (AI) is revolutionizing flow cytometry, particularly with imaging flow cytometry (IFC). IFC merges flow cytometry with optical microscopy, enhancing screening capabilities. AI-powered automated image analysis, as seen in Attune CytPix software, accelerates data processing, accomplishing tasks in minutes that previously took years for experts. In clinical settings, AI and machine learning augment flow cytometry workflows, providing valuable tools for research and diagnostics. The integration of AI into flow cytometry is not magic but a logical step due to the widespread availability and frequent use of cytometry-based assays in various domains. Combining AI with imaging flow cytometry represents a promising platform for intelligent and efficient analysis.

AI plays a pivotal role in imaging flow cytometry, combining the strengths of flow cytometry and optical microscopy. This powerful screening technique offers improved analytical capabilities. In March 2023, ThinkCyte launched a cell sorting platform, VisionSort, the world’s first dual-mode, AI-driven cell characterization and sorting platform. VisionSort combines traditional fluorescence flow cytometry with high-dimensional morphological profiling and AI technology. This innovation accelerates research, diagnostics, and therapeutic developments, marking a significant leap forward in the capabilities of flow cytometry technology. The synergy of AI and flow cytometry not only enhances efficiency in diagnostics but also opens new frontiers in understanding cellular dynamics, paving the way for innovative advancements in medicine and life sciences.

Advances In Fluorescent Dyes For Flow Cytometry

Recent advances in fluorescent dyes for flow cytometry have revolutionized cellular analysis. Quantum dots, nanobodies, and organic dyes with enhanced brightness and photostability enable high-resolution, multiparametric studies. Far-red and near-infrared dyes minimize spectral overlap, improving the detection of rare cell populations. Photoactivatable and photoswitchable dyes provide temporal control, facilitating dynamic imaging. Additionally, environmentally sensitive dyes offer insights into cellular microenvironments. Advances in bioconjugation chemistry enhance specificity, allowing precise targeting of cellular components. These innovations collectively empower researchers with unprecedented capabilities, enabling accurate and comprehensive investigations of complex biological systems using flow cytometry.

Amidst the evolving medical landscape emphasizing personalized therapeutic approaches, the significance of fluorescent banding grows substantially. This technique proves pivotal in distinguishing cell subpopulations within diverse samples, crucial for diagnosing diseases, monitoring treatment effectiveness, and unraveling disease mechanisms. The capacity to intricately scrutinize the cellular makeup of the immune system, tumors, and various biological specimens with precision underscores the importance of these sophisticated labeling techniques. At the core of modern flow cytometry lies the ongoing improvement and utilization of fluorescent banding techniques, elevating its capability as a sophisticated detector of nuanced biological details.

Related Reports:

Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End-user, Region - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]